Iqvia Holdings Inc.
IQVQ2 2025(IQV Q1 FY2025)Estimated4% AI
AI Revenue %
4%
AI Fair Value
$874.8M
AI Revenue (Q)
$149.5M
Total Revenue (Q)
$3.7B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
No AI revenue breakout. TAS segment was $1,546M (40.4% of $3,829M total). AI penetration of TAS estimated at ~10% = ~$155M, or ~4.0% of total revenue. IQVIA continues to integrate AI across its platform but provides no quantification.
Analyzed by claude-opus-4-6
Quoted Figures
Technology & Analytics Solutions revenues $1,546M; Total revenues $3,829M for Q1 2025
10-Q filed 2025-03-31, Segment Data
AI Products Identified (Ring 1)
IQVIA Connected Intelligence (Healthcare-grade AI)AI-powered clinical trial optimizationAI-driven real world evidence analyticsAI-enhanced commercial analytics
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Traditional data subscriptionsLegacy analytics platformsClinical research services (non-AI CRO)Contract sales and medical solutions
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix